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Abstract

L-Proline is an amino acid widely used in pharmaceutical and biotechnological
research due to its catalytic activity and biological relevance. L-Proline has been
recognized and utilized as an organocatalyst, which allows cleaner, more sustainable
reactions. However, one issue with L-proline is its low solubility in organic systems,
limiting its reactivity and efficiency, especially when considering industrial research.
Two reactions that utilize L-Proline are the Michael and Aldol but require 100 mol% of
L-Proline and 30 mol% of L-Proline, respectively. This research will focus on the
synthesis of an analogue of L-Proline utilizing inexpensive, commercially available
reagents. A variety of organic reactions are used to generate the analogue whose structure
is adapted for better solubility. The analogue is known to the Masterson research group
and involves a multi-step synthesis, so efforts to improve the current synthetic strategy
were made to maximize the efficiency of the production for the analogue. The current
method has shown to be the most efficient pathway allowing maximum production at
each step. Future goals for the project will include using organic reactions, including
Aldol and Michael, to analyze the solubility and reactivity of the analogue and compare
with studies performed with L-Proline.

Key Terms: Organic Synthesis, Organocatalyst, L-Proline
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CHAPTER 1: Introduction
A catalyst decreases the activation energy to allow reactions to occur at faster
rates. There are numerous reactions that take days or weeks to go to completion; in the
presence of a catalyst, these times can be dramatically reduced. Catalysts can be seen in
organisms to aid in biological processes or to increase the efficiency of industrial
research. There are a variety of catalysts used in chemistry, such as organocatalysts,
organometallic catalysts, and enzyme catalysts. However, there are benefits to using
specific catalysts for certain reactions.
Organocatalysts have contributed to advancements in sustainable chemistry. The
availability of organocatalysts from natural molecules or variations of natural molecules
is a major benefit, allowing the production of organocatalysts to be relatively
inexpensive. Since the catalysts are chiral, there are different enantiomers of the catalysts
that can exist. Enantiomers are chiral molecules with the same molecular composition
and are mirror images of each other; however, enantiomers cannot be overlapped
perfectly, or are not superimposable. Peoples’ feet and hands are examples of chiral
objects. Despite being mirror images, a person’s hands cannot be overlapped where the
thumbs perfectly align facing the same direction.
Enzyme catalysts do not readily make both enantiomers. This is desirable because
the production of both enantiomers in equal yield, a racemic mixture, is not very useful if
one enantiomer cannot be extracted from the other. Also, the amount of product yielded
is reduced because starting material is being used to create the second enantiomer.
However, the possible applications for enzyme catalysts are lowered because both
enantiomers are not simultaneously available. Unlike organometallic catalysis, the
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absence of transition metals in organocatalysts prevents the production of hazardous
heavy metal waste and allows “cleaner” synthetic reactions.
The “cleaner” reactions reduce the amount of heavy metal pollution that can result
from using organometallic catalysts. This is very beneficial for pharmaceutical
companies because the amount of heavy metals in medications is also reduced. The
availability of both enantiomers is very helpful in producing different drugs. Each
enantiomer could have different biological properties, which allows a drug to have
multiple uses depending on the enantiomer.
One organocatalyst that is widely used in pharmaceutical research is L-Proline. LProline can be found in cartilage and helps the preservation of heart muscles. It is used in
a variety of chemical reactions, especially the Aldol, Mannich, and Michael reactions
because L-Proline is capable of allowing the production of one enantiomer over the other
in these reactions, which is known as stereoselectivity. The stereoselectivity of L-Proline
makes it a popular catalyst. However, L-Proline is not very soluble in organic solvents.
Due to the low solubility, large amounts of the catalyst are then needed for the reactions,
which is inefficient. One solution to this problem is to generate analogues of L-Proline
that have better solubility.
Figure 1a: Comparison of L-Proline and Analogue

2

This research will focus on the application of an analogue of L-Proline, (R)-3Methylpyrrolidine-3-Carboxylic Acid (Figure 1). There are a few structural differences
between L-Proline and the analogue. The main difference between the two catalysts is the
stereochemistry (L-Proline is S, and the analogue is R). There is also a methyl group on
the chiral carbon, which is expected to improve the solubility. The amine group is farther
away from the chiral center, but this is due to the experimental design used to generate
the analogue. Specifically, the solubility and reactivity of (R)-3-Methylpyrrolidine-3Carboxylic Acid will be analyzed using different organic reactions, including the Michael
and Aldol reactions seen in Scheme 1a and Scheme 2a.

Once the solubility of the catalyst has been determined, the selectivity of the reaction will
be studied by analyzing the enantiomeric excess of the enantiomers. This data will then
be compared to L-Proline to determine if (R)-3-Methylpyrrolidine-3-Carboxylic Acid is a
more efficient catalyst.
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CHAPTER 2: Literature Review
Chiral molecules have major advantages in the pharmaceutical industry. Due to
the production of enantiomers, the possibilities for biological applications are increased.
Enantiomers have the potential to behave differently due to the spatial arrangement of the
functional groups. Because the configurations of two enantiomers are different, the
interaction of one enantiomer with a drug can differ from the interaction of the second
enantiomer with the same drug. Previously, artificial drugs were not chiral, but the
majority of drugs developed from natural sources were chiral1.
L-Proline is a popular organocatalyst that is naturally abundant in both of its
enantiomer forms. Because it exists in nature, proline is an inexpensive chiral molecule.
The two functional groups on proline, the carboxylic acid and the amine group (Figure
1), allow the catalyst to act as both an acid and a base. This versatility allows proline to
participate in a variety of reactions. The key feature to proline is its ability to catalyze
reactions to produce stereoselective molecules. If two enantiomers had opposing
functionalities but were produced simultaneously in equivalent ratios (racemic mixture),
then the reaction would be less efficient if only one functionality was needed. Therefore,
stereoselective reactions allow one enantiomer to be produced in excess, maximizing the
efficiency of the reaction2.
The Michael reaction has primarily been studied using enamines with nitro
olefins, but enamine catalysis has not been as thoroughly explored. Proline is a starting
point for the enamine catalysis using asymmetric Michael reactions (Scheme 1). A recent
study used proline in DMSO and methanol solvent systems for ketones and nitro-olefins,
which can be seen in Scheme 1.
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Scheme 1b: Example of Michael Reaction

The study produced yields as high as 96%. These reactions did not require harsh
conditions such as high/low temperatures, inert atmospheres, or metallic salts. However,
the key issues in these experiments were the low enantioselectivities and high reaction
times. The highest enantioselective excess reported was 37% when R = CO2Et (ethyl
ester), R1 = Me (methyl group), and R2 = Et (ethyl group). This set of conditions also
gave the 96% yield. Since this process has not been thoroughly studied, (R)-3Methylpyrrolidine-3-Carboxylic Acid will be used to try and improve the
enantioselectivity of the Michael reaction products.3
Another issue with L-proline is its solubility in organic solvent systems, although
it is very soluble in aqueous systems. The catalyst has been used in Aldol reactions to
generate carbon-carbon bonds, but the low solubility of proline in organic systems, 50
mol% of L-Proline in methylene chloride, causes low product yields.4
Figure 1b: Comparison of Unsubstituted and Substituted Catalysts

Unsubstituted Catalyst

Substituted Catalyst

This study also required large amounts of the catalyst to be used, which is not very
efficient. One way the study improved the results was by substituting a methyl group on
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the chiral carbon on the catalyst, which is seen in Figure 2. This improved the solubility
in nonpolar organic solvents. The substituted analogue allowed good product yields with
increases in enantioselectivity compared to the unsubstituted catalyst. By placing
substituents on the analogues of L-proline, it is possible the solubility of the catalyst can
be increased in not only the Mannich reaction but other reactions as well, including the
Michael reaction (Kazuhiro, et. al). The objectives of my research are to synthesize the
analogue (R)-3-Methylpyrrolidine-3-Carboxylic Acid of L-Proline and test its catalytic
activity in the Michael reaction5

CHAPTER 3: Methodology
Catalyst Production:
Before (R)-3-Methylpyrrolidine-3-Carboxylic Acid can be tested in the Michael
reaction, the catalyst must be synthesized. The synthetic route developed by the
Masterson research group at the University of Southern Mississippi will be used as a
reference in making the catalyst, however the main goal in this project was to optimize
the reaction conditions to provide the most efficient and inexpensive reaction pathway.
The synthesis begins with diethyl methylmalonate. This malonate is chosen
because one of the goals is to have a methyl group substituted on the catalyst. Therefore,
substituted diesters have been used for the starting point. This malonate undergoes an SN2
reaction. In this SN2 process, the acidic hydrogen between the two ester groups is
removed by sodium hydride (NaH) to generate an enolate and hydrogen gas (H2) seen in
Scheme 2.
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Scheme 3a: Generation of Enolate

The enolate then attacks one of the carbons on the dibromoethane while bromine leaves
simultaneously. In this reaction (Scheme 3), a 1:2 molar relationship between the
nucleophile (enolate) and dibromoethane is usually utilized. However, a purification step
is needed to remove excess starting material. Therefore, a 1:1 molar ratio will be used in
this research to try and eliminate the purification step. Other reaction conditions
including the solvent system and refluxing (addition of heat) will also be manipulated to
optimize the reaction.
Scheme 3b: Substitution of Diethyl Methylmalonate

Formation of sodium bromide (NaBr) is an indication that the reaction occurred.
The second step of the synthesis is the Gabriel Synthesis (Scheme 4), which is
also an SN2 reaction. This takes the previous product to react with potassium phthalimide.
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Scheme 4a: Gabriel Synthesis

Again, formation of the salt potassium bromide (KBr) could indicate the reaction
occurred, but NMR spectroscopy will be used to confirm the reaction took place. This
step introduces the nitrogen necessary for the amine seen in the catalyst.
In the third step the chiral center of the catalyst is formed with the formation of a
carboxylic acid from one of the esters. This is a hydrolysis reaction (Scheme 5) with Pig
Liver Esterase (PLE) in a pH 7.4 buffer.
Scheme 5a: PLE Hydrolysis

Once the chiral center is generated, para-nitrobenzyl bromide is substituted for
the hydrogen on the carboxylic acid. This step will help direct cyclization to form the
pyrrolidinone ring. The addition of para-nitrobenzyl bromide is also a director for the S
stereochemistry (Scheme 6). This is a novel reaction designed by the Masterson Research
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Group. Multiple groups can be substituted on the benzene ring, and these groups will also
affect the stereochemistry of the catalyst.
Scheme 6a: Addition of Para-Nitrobenzyl Bromide

Once the benzene is added, the cyclization step can occur to form the pyrrolidinone ring
seen in Scheme 7. Depending on how the cyclization occurs, the R or S enantiomer can
be produced. If cyclization occurs on the side with the benzene, the S enantiomer is
produced (Scheme 7). If cyclization occurs on the side with the ester group, the R
enantiomer is produced (Scheme 7). This selective step is novel in the Masterson
research lab and a variety of functional groups were used to test selectivity.67 Using paranitrobenzyl bromide, as seen in Scheme 7, allowed a 78:1 molar ratio of S:R.
Scheme 7a: Selective Cyclization

After cyclization, a phenyl group will be added to the compound using benzyl
bromide (Scheme 8). Again, this is an SN2 reaction using sodium hydride to generate the
nucleophile from starting material.
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Scheme 8a: Addition of Benzyl Group to Nitrogen

Scheme 9: Formation of Thioketones

Once the thioketone is formed, it can be removed using Raney-nickel catalyst in Scheme
108910.
Scheme 10: Removal of Thioketones

Lithium hydroxide (LiOH) will be used to convert the remaining ester group to a
carboxylic acid group, generating the same product from the two reactants (Scheme 11).
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Scheme 11: Generating Carboxylic Acid

The final step is the removal of the benzene group seen in Scheme 12. This will
be done using hydrogen and palladium catalyst.
Scheme 12: Formation of Target Catalyst

Once the benzyl group is removed, the synthesis of the catalyst is complete. Because this
reaction is known in the Masterson laboratory, optimization of the synthesis will be a
potential goal for certain steps. The complete synthetic route is displayed in Scheme 13.11
Once enough of the catalyst is generated, it can be tested in the Michael reaction.
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Scheme 13: Complete Synthesis of (R)-3-Methylpyrrolidine-3-Carboxylic Acid

Experimental Procedure:
The protocol utilized in this studied was based on the synthetic route developed by Dr.
Banerjee and the Masterson Research Group.
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General Methods:
“THF, CH2Cl2, and DMF were dried by passage through activated alumina. All reagents
were used as received unless otherwise stated. Flash chromatography was performed
using P-60 silica gel, and TLC analysis was performed using silica precoated TLC plates.
Pig liver esterase (PLE) refers to the commercially available crude preparation12.”

Synthesis of Diethyl 2-(2-Bromoethyl)-2-methylmalonate (1):
Approximately 65 mL of dry THF was added to 2.35 g of NaH (58.5 mmol, 60%
suspension in mineral oil) under N2 atmosphere before being cooled to 0C. A solution of
10.2 g of diethyl-2-methylmalonate (58.6 mmol) in THF was added over 20 minutes,
with stirring at rt. A solution of 10.9 g dibromoethane (58.0 mmol) in THF was added
dropwise with stirring under N2 atmosphere. The reaction mixture refluxed overnight.
Half the solvent was evaporated under reduced pressure, and the solution was diluted
with a 5% solution of HCl and water. The mixture was washed with CHCl3 (3 X 30 mL),
washed with brine, dried over MgSO4, and filtered. The remaining solvent was
evaporated under reduced pressure. The resulting yellow liquid was distilled to remove
the excess dibromoethane, diethyl-2-methylmalonate, and THF giving 9.0 g (29 mmol,
47%) of 1 as a yellow liquid. 1H NMR corresponded to literature.

Synthesis of Diethyl 2-Methyl-2-[2-(1,3-dioxoisoidndolin-2-yl)ethyl)malonate (2):
Approximately 6.8 g of 1 (22.4 mmol) was placed in a 250 mL sealed tube with 120 mL
DMF. A 5.3 g (28.6 mmol) portion of potassium phthalimide was added to the sealed
tube. The reaction mixture stirred at 90C overnight. The reaction mixture was cooled to
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rt, diluted with 300 mL of H2O, and extracted with Et2O (3 X 200 mL). The combined
organic layer was washed with water (10 X 100 mL), washed with brine (2 X 100 mL),
dried over MgSO4, filtered, and evaporated under reduced pressure giving the crude
product was a white solid. The crude was recrystallized from cold Et2O giving 1.62 g (4.4
mmol, 23%) of 2 was a white solid. 1H NMR corresponded to literature.

Synthesis of (R)-2-(N-Ethylphthalimido)-3-ethoxy-2-methyl-3-oxopropanoic Acid (3):
A 6.5 g portion of 2 (17.6 mmol) was add to 610 mL of phosphate buffer (0.1 N, pH 7.4)
with stirring. An 89.3 mg portion of pig liver esterase (PLE) (27 units/mg, 90 unites per
mmol of the substrate) was added to the buffer. The pH was maintained with an auto
buret set to deliver 1 equivalent of 1 N NaOH solution to keep a pH of 7.4. The
hydrolysis proceeded overnight. The pH was lowered to 1 with concentrated HCl and
extracted three times with 600 mL of Et2O. The combined organic layer was dried over
MgSO4, filtered, and concentrated under reduced pressure giving 1.87 g (5.5 mmol, 31%)
crude product as yellow viscous oil. 1H NMR corresponded to literature.

Synthesis of (S)-1-(4-Nitrobenzyl)-3-ethyl-2-methyl-[2-(1,3-dioxoisoindolin2yl)ethyl]malonate (4):
A portion of 0.76 g of K2CO3 (5.5 mmol) was added to a solution of 1.87 g of 3 (5.5
mmol) in 20 mL of DMF. Approximately 1.1 g (5.1 mmol) of para-nitrobenzyl bromide
was slowly added to the solution. The reaction stirred overnight under an N2 atmosphere.
The reaction mixture was then diluted with 20 mL of water and washed with Et2O (3 X
20 mL). The combined organic layer was washed with water (5 X 20 mL), washed with
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brine (2 X 20 mL), and dried over MgSO4. The solvent was removed under reduced
pressure, and 1.79 g (3.8 mmol, 76%) of 4 was obtained as a white solid. 1H NMR
corresponded to literature.

Synthesis of (R)-Ethyl 3-Methyl-2-oxopyrrolidine-3-carboxylate (5):
Approximately 400 microliters (4.1 mmol) of 35% hydrazine in water was added to 1.69
g (3.5 mmol) 4 in solution with 24 mL of MeOH. The reaction mixture was refluxed
overnight, resulting in the formation of white precipitate. The solution was cooled to rt
and filtered. The solvent was removed from the filtrate under reduced pressure to obtain a
solid, which was put back into solution with CH2Cl2. The solution was washed with H2O
(1 X 100 mL), and the organic layer was dried with MgSO4, filtered, and placed under
reduced pressure. The resulting solid was “chromatographed using 30% hexanes/EtOAc”
producing 0.2 g (0.8 mmol, 25%) of 5 as pure white solid. 1H NMR corresponded to
literature.

Synthesis of (R)-Ethyl 1-Benzyl-3-methyl-2-oxopyrrolidine-3-carboxylate (6):
A volume of 2 mL anhydrous THF was added to 0.4 g (1.8 mmol) of 5. The solution was
slowly added to 0.07 g NaH (2.9 mmol) in (volume) of THF at 0C under a N2
atmosphere and stirred for 5 minutes. Approximately 0.3 g of BnBr (1.8 mmol) was
added dropwise, and the mixture stirred for 10 minutes at C. The reaction was warmed
to rt and continued for 1 hour at rt. Dry DMF 10 mL was added to the reaction and
continued stirring for 2 h. The mixture was added to 7 mL of H2O where the water layer
was extracted with Et2O (3 X 20 mL). The combined organic layer was washed with
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water (5 X 20 mL) and dried over MgSO4. The solvent was removed under reduced
pressure, and the resulting oil was “chromatographed (gradient, 15-20%
EtOAc/hexanes)” allowing 0.14 g (0.5 mmol, 19%) of 6. 1H NMR corresponded to
literature.

Michael and Aldol Reactions:
To test the reactivity of the analogue, a series of trials will be conducted for the
Michael and Aldol reactions. These will include different solvent systems, protic and
aprotic, to see if better enantioselectivity is seen compared to the literature values of Lproline. Potential reactions for the study are displayed in Schemes 14a-b, but the
analogue will be used in place of (S)-proline.

Scheme 14a: Michael Reaction

Scheme 14b: Aldol Reaction
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Once each of the reactions has been conducted, the enantioselectivity of each experiment
will be compared to the literature values of the (S)-proline reactions.
CHAPTER 4: Results
Synthesis of Catalyst
Scheme 3c: Alkylation of Diethyl Methylmalonate

Molar Ratio of
Amount of
Diethyl
Trial

Methylmalonate

Solvent

Diethyl

Percent

Methylmalonate

Yield

Reflux

to
Used
Dibromoethane
1

1:1

DMF

No

5 mL

51.57

2

1:1

THF

No

10 mL

55.11

3

1:1

THF

Yes

10 mL

10.10

4

1:1

THF

Yes

40.81 g

87.96

5

1:1

THF

Yes

40.80 g

16.57

6

1:1

THF

Yes

20 mL

9.60

7

1:1

THF

Yes

20 g

47.24

Table 1 displays different trials for the alkylation of diethyl methylmalonate using
different reaction conditions with yields. The table specifies the solvent used, quantity of
diethyl methylmalonate used, and whether or not the solution was refluxed.
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Figure 2 depicts the NMR for the alkylation product. The peaks and values correspond to
Dr. Banerjee’s reported spectrum.
Scheme 4b: Gabriel Synthesis

Amount of Starting
Trial

Percent Yield
Material Used

1

10.91 g

9.79

2

6.76 g

22.90

3

16.63 g

36.15

Table 2 shows the amount of starting material used for each trial in the Gabriel Synthesis
and the corresponding percent yield.
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Figure 3 depicts the NMR for the substituted product. The peaks and values correspond
to Dr. Banerjee’s reported spectrum.
Scheme 5b: PLE Hydrolysis

Amount of Starting
Trial

Percent Yield
Material Used

1

1.32 g

55.23

2

6.74

21.57

3

6.80 g

24.94

4

6.50 g

31.13

Table 3 shows the amount of starting material used for each trial in the PLE Hydrolysis
and the corresponding percent yield.
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Figure 4 depicts the NMR for the chiral product. The peaks and values correspond to Dr.
Banerjee’s reported spectrum.

Scheme 6b: Substitution of Para-Nitrobenzyl Bromide

Amount of Starting
Trial

Percent Yield
Material Used

1

2.05 g

38.33

2

1.87 g

76.20

Table 4 shows the amount of starting material used for each trial in the reaction and the
corresponding percent yield.
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Figure 5 depicts the NMR for the substituted product. The peaks and values correspond
to Dr. Banerjee’s reported spectrum.
Scheme 7b: Selective Cyclization

Amount of Starting
Trial

Percent Yield
Material Used

1

1.69 g

38.33

Table 5 shows the amount of starting material used in the cyclization step and the
corresponding percent yield.
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Figure 6 depicts the NMR for the cyclized product. The peaks and values correspond to
Dr. Banerjee’s reported spectrum.

Scheme 8b: Addition of Benzyl Groups

Amount of Starting
Trial

Percent Yield
Material Used

1

0.4435 g

27.72

Table 6 shows the amount of starting material used in the addition and the corresponding
percent yield.

22

O
OO

O

O

O
O

BnBr
N Bn
NH

NaH

O

O
N

Bn

Figure 7 depicts the NMR for the benzyl-substituted products. The peaks and values
correspond to Dr. Banerjee’s reported spectrum.
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Scheme 15: Steps Completed in Synthesis

CHAPTER 5: Discussion
Looking at the individual steps in the synthesis, one can conclude the current
synthetic pathway is most optimized for this analogue. When considering the first step,
the goal was to reduce the need for purification. The protocol for purification involved
distillation, which is a time-consuming process, and the presence of starting material
indicated the reaction was not going to completion. Changing the molar ratio of diethyl
methylmalonate to dibromoethane to 1:1 was a proposed solution because it would
decrease the amount of starting material leftover from the reaction. However, purification
was still needed with this molar ratio as seen in the NMR (Figure 3). A peak around 1.5
ppm that integrates to 1.39 signifies the presence of unreacted diethyl methylmalonate.
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Also, the reaction yields (Table 1) were half the yield reported with the 2:1 molar ratio.
Trial 4 has a high percent yield but it is believed to be due to a tear mass error. Changing
the solvent system and reflux conditions did not really change this outcome. Another
issue with early trials was deciding which reactant was in excess. The procedure said to
add the generated enolate to dibromoethane, but errors in technique had the
dibromoethane being added to the enolate. This could have affected the rate of the
reaction and prohibited the reaction from reaching completion. However, low yields were
still being seen when the generated enolate was added to dibromoethane. Therefore, it
was decided the current synthetic pathway with the 2:1 molar ratio provided the most
optimized and efficient reaction conditions.
Once enough alkylated diester was produced, the next reaction was the Gabriel
Synthesis, which replaced the bromide with a phthalimide group. This step does not have
an extensive purification process like the previous because the product crystallizes pure
out of solution after work up. The first few trials have low yields (Table 2), and the NMR
(Figure 3) is pure for the crude product except for some remaining phthalimide but not
enough to cause concern.
The following step was the addition of para-nitrobenzyl bromide. Trial 1 showed
a low yield but required purification by column. Column purification is very tedious and
loss of mass can be an issue, especially if beginning with low mass. Therefore, the low
yield could be contributed to having a small scale (2.05 g starting material). Also, this
reaction must be stopped after a certain amount of time or the desired product will start
reacting again. Therefore, it is possible not all of the para-nitrobenzyl bromide was added
in the reaction. Trial 2, however, shows improvement in yield with no purification
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needed, so technique could also have contributed to the low yield in Trial 1. NMR
analysis (Figure 5) showed purified material after purification for Trial 1.
The cyclization of the phthalimide group had a low yield (38.33%), but the
reported yield was 40%. Therefore, despite the “low” yield, the reaction went very well
because it is known to be a low-yielding step. Column purification was also utilized in
this step but not much mass loss was seen. After purification, NMR (Figure 6) showed
purified product. This reaction also had a small scale due to the low yield in the paranitrobenzyl bromide substitution reaction, so lack of material was staring to become a
concern when this step produced less than a gram of material.
After cyclization, benzyl groups were added to the amine and ester groups as
demonstrated in Scheme 8, which actually give two products. NMR analysis confirmed
the production of both products (Figure 7), which complicates the spectra, but peaks at
2.5 ppm and 3.25 ppm confirm the diasteric hydrogens. As seen in Scheme 13, having
two products is not a concern because both will lead to the catalyst in the synthetic route.
This step also had a low yield, but column purification was also needed after working up
the reaction. Therefore, loss of mass could have also resulted from running a column,
especially since less than a gram of material was used for starting material.
Limitations
The synthesis of the catalyst (R)-3-Methylpyrrolidine-3-Carboxylic Acid was not
completed. This was due to a variety of factors relevant to specific steps in the synthesis.
Specifically, lack of material prevented the advancement of synthesis, and time had to be
taken to build up starting material at various points during the project.
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The first step in the synthesis, the alkylation of diethyl methylmalonate, took the
longest since attempts at optimization were taken. The original synthetic strategy calls for
a 1:2 molar ratio of diethyl methylmalonate to dibromoethane. However, purification was
needed in this step due to the presence of starting material. In this project, one of the
goals was to manipulate the reaction conditions to minimize the amount of starting
material leftover from the reaction. Therefore, a 1:1 molar ratio of diethyl
methylmalonate to dibromoethane was suggested as an initial change. Table 1 shows
differences in other conditions such as solvent, reflux, and scale size of each optimization
trial. The percent yield for each trial was also measured for comparison to the yield of
original reaction conditions. Due to the low yields observed, more time was taken to
generate enough material to continue the synthesis.
During the PLE hydrolysis step, there were some issues with electrodes of the
titrator that influenced the reaction. During the titration, a set amount of base was
expected to be added but only half of that amount was being added during Trials 2-3.
During calibration of the electrodes, the electrodes were not stabilizing. This limited the
production of the chiral product and lowered the yield of this reaction.
For several of the reactions, column chromatography was used for purification.
This is a very tedious, time-consuming process. Columns were more relevant towards the
end of the synthetic route when material was low, so extra care was given while running
columns to insure all products were removed from the columns for maximum yields;
however, loss of mass is a possibility when using columns.
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CHAPTER 6: Conclusions
This study suggests the established synthetic pathway is the most optimized for
the desired analogue (R)-3-methylpyrolidine carboxylic acid. The reaction yields above
are significantly lower than those reported by the Masterson Research Group, so the
focus of the research shifted to completing the synthesis of the analogue instead of
optimization. Once the analogue is produced, its solubility and catalytic reactivity will be
tested and compared with L-proline’s.
Future Research
Future goals of the project include completing the synthesis of the catalyst.
Because the last successful step was the addition of para-nitrobenzylbromide, the
remaining steps include Lawesson’s, Raney-Ni, acid/base, and catalytic hydrogenation
reactions. Once the catalyst is synthesized, enough must be generated for catalytic studies
of Michael and Aldol reactions. The solubility of the catalyst and stereoselectivity of the
reactions will be observed and compared to literature data on reactions with L-proline.
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